Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Beginning in 1992, the GAO notes, the DEA defined "accepted medical use" based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy."
Simplified Text
The Government Accountability Office (GAO) notes that the Drug Enforcement Administration (DEA) defined "accepted medical use" using five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy," starting in 1992.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "date": "1992"
}
Subject Tags
Regulation Drug Policy GAO Report
UUID
7d1e03ac-3328-4ef9-a2b8-119973d08d2c
Vector Index
✗ No vector
Created
September 30, 2026 at 10:01 PM (1 week ago)
Last Updated
September 30, 2026 at 10:01 PM (1 week ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://reason.com/2026/09/30/hazy-federal-criteria-for-classifying-drugs-invite-arbitrary-bureaucratic-judgments
Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments
Completed Analysis
10 claims 🔥
1 week ago
https://reason.com/2026/09/30/hazy-federal-criteria-for-classifying-drugs-invite-arbitrary-bureaucratic-judgments

A GAO report notes that the Controlled Substances Act (CSA) does not define "potential for abuse" or "accepted medical use," leading to arbitrary bureaucratic judgments. This lack of clarity has significant criminal justice implications, as seen in the historical treatment of cannabis.

Drug Policy Controlled Substances Act Drug Classification Government Accountability Office DEA FDA Cannabis Reclassification

Similar Claims (5)

Other claims identified as semantically similar to this one.